Navigation Links
PsiPort ™ Mass Directed Auto Purification Software from Shimadzu Biotech

ProductsPsiPort ™ Mass Directed Auto Purification Software from Shimadzu Biotech
Company Shimadzu Biotech
Item PsiPort ™ Mass Directed Auto Purification Software
Price 
Description Shimadzu Biotech presents PsiPort Mass Directed Auto Purification software, a web-based data review and data acquisition system designed for automated compound isolation and purification for the life science and pharmaceutical discovery programs. The system has been designed specifically to simplify high throughput mass directed auto purification for synthetic chemists using a simple, intuitive, graphical user interface operating within Internet Explorer. PsiPort is the Web-based solution for sample log-in and interactive data review (Microsoft Internet Explorer browser shows MS chromatogram, MS spectrum, UV chromatogram and associated fraction id) and features a fully distributed client-server architecture for data review either within a secure company intranet or over the Internet.

Key features

  • Chemists and biochemists do not need to be trained on mass spectrometry software.
  • Web-based solution for sample log-in and interactive data review (Microsoft Internet Explorer browser shows MS chromatogram, MS spectrum, UV chromatogram and associated fraction id).
  • Automates compound isolation and purification through a single web-based interface (enter target mass information through a wizard or use Microsoft Excel).
  • Fully distributed client-server architecture for data review either within a secure company intranet or over the Internet.
Software design
PsiPort Mass Directed Auto Purification software has been designed in a two tier approach to accelerating compound isolation and purification through a generic web based interface.

Access to PsiPort
Access to the PsiPort system is managed and controlled by the System Manager | Administrator to provide full system security. Access can be either local or remote using the integrated client-server support (Microsoft Internet Information Services).

Sample log-in and acquisition
Chemists may submit samples either using a spreadsheet from an external database (Microsoft Excel for example) or a wizard function for a limited number of samples. Each sample contains all the user defined acquisition information (for example target mass, formulae, MS and UV thresholds and a pre-assigned LC/MS method which also includes a specific customized report layout).

Info Shimadzu BiotechShimadzu Biotech
Japan/Asia
Shimadzu Corporation
1 Nishinokyo Kuwabaracho
Nakagyoku, Kyoto 604-8511
Japan
Phone: +81-75-823-1148
Fax: +81-75-823-1364
info@shimadzu-biotech.net

United States
Shimadzu Biotech USA
7102 Riverwood Drive
Columbia, Maryland 21046 USA
Phone: 800-477-1227/410-381-1227
info@shimadzu-biotech.net

England
Shimadzu Biotech
Wharfside
Trafford Wharf Road
Manchester
M17 1GP
England
Tel +44 161 888 4414
Fax +44 161 888 4402
MALDI
chris.sutton@kratos.co.uk
LCMS
nl@shimadzu.de

For contacts in other regions
please click here.

Customer Service: see above
Fax Number: see above
Web Site: http://www.shimadzu-biotech.net
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Cleland’s REDUCTACRYL™ Reagent from Calbiochem
2. Transformance™ competent cell preparation service from Lucigen
3. EvoQuest ™ Custom Laboratory Services from Invitrogen
4. GST•Tag™ Antibody Plate from Novagen
5. pTriEx™-4 DNA from Novagen
6. ReBlot™ Plus Kit - Trial from CHEMICON
7. NanoMate ™ 100 with ESI Chip Technology from Advion Biosciences, Inc.
8. GrabIt™ Protein G Plus/Protein A Kit from Novagen
9. Cell invasion Fluorometric (green) Assay Kit, InnoCyte™ from Calbiochem
10. mirVana™ miRNA Bioarray Essentials Kit from Ambion
11. CaspaTag™ Pan-Caspase In Situ Assay Kit, Sulforhodamine from CHEMICON
Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297...
This application changes sensitive keywords in an FCS file to remove patient information. It was contributed by Dr. David Miller....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products:
(Date:8/20/2015)... Aug. 20, 2015   Sensory, Inc ., ... the user experience and security of consumer electronics ... announced that its TrulySecure™ is the ... to be FIDO Certified™. The FIDO ... with the FIDO UAF (Universal Authentication Framework) 1.0 ...
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
... never reach the tumors they,re intended to treat, ... the blood vessels feeding the tumors are abnormal"leaky ... Judah Folkman, MD, founder of the Vascular Biology ... researchers have discovered an explanation for these abnormalities ...
... 75% of fertilizers and fertilizer technology used around the ... to 1970s by scientists and engineers at the Tennessee ... Shields, a former TVA official. Shields is now Interim ... and Agricultural Development, based in Muscle Shoals, Alabama. ...
... A group of Yale undergraduates have discovered dozens of ... the Amazon rain forest, including several so genetically distinct ... taxonomical genera. The analysis of 135 endophytes - ... of plants - by members of the Rain Forest ...
Cached Biology News:Normalizing tumor vessels to improve cancer therapy 2Normalizing tumor vessels to improve cancer therapy 3TVA fertilizer technology used worldwide -- but few new products since 1970s 2TVA fertilizer technology used worldwide -- but few new products since 1970s 3TVA fertilizer technology used worldwide -- but few new products since 1970s 4Yale undergrads' Amazon trip yields a treasure trove of diversity 2
(Date:9/2/2015)... Virginia , September 2, 2015 ... of the winners of the 2015 BeHEARD science challenge, ... that offers rare disease researchers, access to the latest ... use its drug repositioning and pathway analytics capability to ... Wylder Nation Foundation in the study of Niemann-Pick Disease ...
(Date:9/2/2015)... 2015  Neurotech Pharmaceuticals, Inc., announced today the ... Phase 2 clinical trial of NT-503 Encapsulated Cell ... subfoveal choroidal neovascularization secondary to age related macular ... endothelial growth factor (VEGF) receptor protein continuously produced ... landmark proof-of-concept study will evaluate NT-503 ECT as ...
(Date:9/2/2015)... Aytu BioScience, Inc. (OTCQB: AYTU), a specialty ... related conditions, announced today that it has closed the ... financing, raising a total of $5.175 million, which includes ... Josh Disbrow , Chief Executive Officer ... intended to be used to conduct clinical studies for ...
(Date:9/2/2015)... 2015 BioLight Life Sciences ... "Company"), a firm that invests in, manages and ... announced today that presentations highlighting its IOPtiMate™ system ... at the Ophthalmology Futures European Forum and the ... & Refractive Surgeons ("ESCRS"), both taking place in ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3